PCM
GSK icon

Pointe Capital Management’s GSK GSK Stock Holding History

Pointe Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-381
Closed -$13.6K – 252
2023
Q1 		$13.6K Buy
+381
New +$13.3K 0.01% 297
2017
Q3 		– Sell
-5,296
Closed -$285K – 154
2017
Q2 		$285K Buy
+5,296
New +$282K 0.2% 128

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pointe Capital Management's GSK Position: Q2 2023 in Review

Pointe Capital Management sold out of GSK (GSK) in Q2 2023, closing a stake of 381 shares — an estimated $13.6K sold.

Pointe Capital Management first reported a position in GSK in Q2 2017 and held it in 2 quarters. The position peaked at $285K in Q2 2017. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • Pointe Capital Management reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • Pointe Capital Management sold 381 GSK shares in Q2 2023, an estimated $13.6K.
  • Pointe Capital Management first reported a position in GSK in Q2 2017 and held it in 2 quarters.
  • Pointe Capital Management's GSK position peaked at $285K in Q2 2017.
  • 827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.